Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. 1990

C H Hannum, and C J Wilcox, and W P Arend, and F G Joslin, and D J Dripps, and P L Heimdal, and L G Armes, and A Sommer, and S P Eisenberg, and R C Thompson
Synergen Inc., Boulder, Colorado 80301.

Three interleukin-1 inhibitors have been purified to homogeneity from medium conditioned by human monocytes. Partial sequence analysis and digestion with N-glycanase indicate that these are glycosylation forms of a single protein. The protein binds to the interleukin-1 receptor but has no interleukin-1-like activity, even at very high concentrations, and is therefore a pure receptor antagonist.

UI MeSH Term Description Entries
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D011971 Receptors, Immunologic Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behavior of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere. Immunologic Receptors,Immunologic Receptor,Immunological Receptors,Receptor, Immunologic,Receptors, Immunological
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002845 Chromatography Techniques used to separate mixtures of substances based on differences in the relative affinities of the substances for mobile and stationary phases. A mobile phase (fluid or gas) passes through a column containing a stationary phase of porous solid or liquid coated on a solid support. Usage is both analytical for small amounts and preparative for bulk amounts. Chromatographies
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance

Related Publications

C H Hannum, and C J Wilcox, and W P Arend, and F G Joslin, and D J Dripps, and P L Heimdal, and L G Armes, and A Sommer, and S P Eisenberg, and R C Thompson
January 1995, Nutrition (Burbank, Los Angeles County, Calif.),
C H Hannum, and C J Wilcox, and W P Arend, and F G Joslin, and D J Dripps, and P L Heimdal, and L G Armes, and A Sommer, and S P Eisenberg, and R C Thompson
January 1993, Advances in immunology,
C H Hannum, and C J Wilcox, and W P Arend, and F G Joslin, and D J Dripps, and P L Heimdal, and L G Armes, and A Sommer, and S P Eisenberg, and R C Thompson
August 1998, Rheumatic diseases clinics of North America,
C H Hannum, and C J Wilcox, and W P Arend, and F G Joslin, and D J Dripps, and P L Heimdal, and L G Armes, and A Sommer, and S P Eisenberg, and R C Thompson
January 1995, Critical reviews in immunology,
C H Hannum, and C J Wilcox, and W P Arend, and F G Joslin, and D J Dripps, and P L Heimdal, and L G Armes, and A Sommer, and S P Eisenberg, and R C Thompson
January 1992, The Journal of investigative dermatology,
C H Hannum, and C J Wilcox, and W P Arend, and F G Joslin, and D J Dripps, and P L Heimdal, and L G Armes, and A Sommer, and S P Eisenberg, and R C Thompson
January 2000, Cancer investigation,
C H Hannum, and C J Wilcox, and W P Arend, and F G Joslin, and D J Dripps, and P L Heimdal, and L G Armes, and A Sommer, and S P Eisenberg, and R C Thompson
January 1998, International reviews of immunology,
C H Hannum, and C J Wilcox, and W P Arend, and F G Joslin, and D J Dripps, and P L Heimdal, and L G Armes, and A Sommer, and S P Eisenberg, and R C Thompson
July 1994, FEBS letters,
C H Hannum, and C J Wilcox, and W P Arend, and F G Joslin, and D J Dripps, and P L Heimdal, and L G Armes, and A Sommer, and S P Eisenberg, and R C Thompson
May 2009, Experimental eye research,
C H Hannum, and C J Wilcox, and W P Arend, and F G Joslin, and D J Dripps, and P L Heimdal, and L G Armes, and A Sommer, and S P Eisenberg, and R C Thompson
July 1994, The Proceedings of the Nutrition Society,
Copied contents to your clipboard!